compounded semaglutide for Women What is compounded semaglutide and
Description
In California, 503A compounding pharmacies may only prepare GLP-1 medications when a patient has an intolerance to FDA-approved versions like Wegovy , Ozempic , Zepbound , or Mounjaro
Until comprehensive safety data are available and regulatory approval is granted, retatrutide should only be administered within the context of an approved clinical trial
This information is used throughout the trial
The medication carries a risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
The percentage of users with negative self-image dropped from 23% before taking GLP-1 to 10% during treatment
